María Carmen Chillón

Summary

Affiliation: Universidad de Salamanca
Country: Spain

Publications

  1. doi request reprint Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia
    M C Chillon
    Department of Hematology, University Hospital of Salamanca and Institute of Biomedical Research of Salamanca, Salamanca, Spain
    Leukemia 26:2360-6. 2012
  2. pmc Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients
    María Carmen Chillón
    Department of Hematology, University Hospital of Salamanca, Paseo San Vicente 58 182, Salamanca, 37007, Spain
    Haematologica 95:745-51. 2010
  3. doi request reprint The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia
    Carlos Santamaria
    Hospital Universitario, Salamanca, Spain
    Haematologica 93:1797-805. 2008
  4. ncbi request reprint Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia
    Carlos Santamaria
    Departament of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
    Haematologica 92:315-22. 2007

Collaborators

  • Ramon Garcia-Sanz
  • F Ramos
  • Carlos Santamaria
  • Ana Balanzategui
  • Jesus F San Miguel
  • Miguel Alcoceba
  • Maria Eugenia Sarasquete
  • Teresa Bernal
  • Maria Jesus Penarrubia
  • Marcos Gonzalez
  • José Antonio Queizán
  • Pilar Giraldo
  • Ramon Garcia Sanz
  • Marcos Gonzalez González
  • Carina Fernández
  • Patricia Martín-Jiménez

Detail Information

Publications4

  1. doi request reprint Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia
    M C Chillon
    Department of Hematology, University Hospital of Salamanca and Institute of Biomedical Research of Salamanca, Salamanca, Spain
    Leukemia 26:2360-6. 2012
    ..These findings indicate that high FLT3 expression identifies MLL-AF4+ ALL patients at very high risk of treatment failure and poor survival, emphasizing the value of ongoing/future clinical trials for FLT3 inhibitors...
  2. pmc Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients
    María Carmen Chillón
    Department of Hematology, University Hospital of Salamanca, Paseo San Vicente 58 182, Salamanca, 37007, Spain
    Haematologica 95:745-51. 2010
    ..Internal tandem duplications of the FLT3 gene (FLT3-ITDs) are frequent in patients with acute promyelocytic leukemia (APL), however its clinical impact remains controversial...
  3. doi request reprint The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia
    Carlos Santamaria
    Hospital Universitario, Salamanca, Spain
    Haematologica 93:1797-805. 2008
    ..The gene for preferentially expressed antigen of melanoma (PRAME) has been shown to be over-expressed in acute promyelocytic leukemia, but its actual incidence and clinical impact are still unknown...
  4. ncbi request reprint Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia
    Carlos Santamaria
    Departament of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
    Haematologica 92:315-22. 2007
    ..Our aim was to analyze any associations between the risk of relapse and RQ-PCR results in different phases of treatment, comparing these data with those yielded by conventional qualitative reverse transcriptase-PCR...